A real-world retrospective study found that adding GLP-1 receptor agonists to hormone therapy may reduce endometrial cancer risk in women with benign uterine or endometrial hyperplasia. This study was...
A retrospective cohort study compared the patient characteristics and postoperative outcomes of those with stage III or IV epithelial ovarian cancer who had same-day discharge following minimally invasive...
Researchers set out to determine whether short-course vaginal cuff brachytherapy regimen maintains quality of life and acceptable toxicity in patients with early-stage endometrial cancer.
A new study has found that vaginal natural orifice transluminal endoscopic surgery for hysterectomy with uterosacral ligament suspension results in shorter surgical times, lower blood loss, and fewer...
A multicenter study revealed significant variations in the administration of postpartum venous thromboembolism (VTE) prophylaxis and highlighted key risk factors influencing its use.
In this respiratory diseases roundup, researchers examine COVID-19 protection, hospitalization rates, long COVID predictors, and rare disease mortality risks.
An ultra-low-dose 0.005% estriol vaginal gel reduced recurrent urinary tract infections in postmenopausal women with genitourinary syndrome of menopause, offering a safe and effective alternative to...
A phase 3 trial subgroup analysis found that adding pembrolizumab to adjuvant chemotherapy may improve disease-free survival in patients with mismatch repair-deficient endometrial cancer, a population at...
A randomized trial found that radiation therapy alone provides better progression-free survival and fewer acute toxicities than chemoradiation for women with localized recurrent endometrial cancer.
A randomized clinical trial found that while low-magnitude mechanical signals did not improve trabecular bone mineral density in adolescents with anorexia nervosa, it significantly increased tibial bone...
